drugset / Trial / NCT03532022

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

NCT03532022

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is an open-label, randomised, titration-blinded, parallel arm, multicenter study to compare twice daily Chronocort® with standard care in participants with Congenital Adrenal Hyperplasia (CAH). This study will be conducted in the USA.

Timeline

Start
2018-10-04
Primary completion
2018-10-17
Completion
2021-07-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 5 mg
Comparator Hydrocortisone Other / unclassified 10 mg
Comparator Hydrocortisone Other / unclassified 20 mg
Comparator Dexamethasone Small molecule
Comparator Hydrocortisone Other / unclassified
Comparator Prednisolone Other / unclassified
Comparator Prednisone Other / unclassified